Poly(lactic acid) for delivery of bioactive macromolecules
- 1 December 2016
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 107, 277-288
Abstract
No abstract availableKeywords
Funding Information
- Connecticut Regenerative Medicine Research Fund (15-RMB-UCHC-08)
- National Science Foundation (IIP-1311907, IIP-1355327, EFRI-1332329)
This publication has 106 references indexed in Scilit:
- F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug deliveryBiomaterials, 2013
- Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapyJournal of Controlled Release, 2011
- Delivery of Therapeutic ProteinsJournal of Pharmaceutical Sciences, 2010
- Drug delivery systems: Advanced technologies potentially applicable in personalized treatmentsEPMA Journal, 2010
- Thyrotropin-releasing hormone d,l polylactide nanoparticles (TRH-NPs) protect against glutamate toxicity in vitro and kindling development in vivoBrain Research, 2009
- Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptidesAdvanced Drug Delivery Reviews, 2008
- Endocytic mechanisms for targeted drug delivery☆Advanced Drug Delivery Reviews, 2007
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Poly(lactide) Stereocomplexes: Formation, Structure, Properties, Degradation, and ApplicationsMacromolecular Bioscience, 2005
- Cell-penetrating peptides: tools for intracellular delivery of therapeuticsCellular and Molecular Life Sciences, 2005